Ostatné · TXG
10x Genomics, Inc.
Fundamenty firmy Healthcare · Medical Devices · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 15 hodnotení
nákup
- Najnižší cieľ
- 40,00
- Priemerný cieľ
- 62,13
- Najvyšší cieľ
- 90,00
- Potenciál
- −34,5 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | -0,02 | -0,04–0,00 | -0,02 | +12,3 % |
| budúci štvrťrok | -0,01 | -0,06–0,05 | 0,07 | −107,1 % |
| tento rok | 0,04 | -0,10–0,18 | 0,12 | −70,2 % |
| budúci rok | 0,08 | 0,01–0,17 | 0,04 | +109,1 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 147,7 mil. | 149,0 mil. | −0,9 % |
| budúci štvrťrok | 171,2 mil. | 166,0 mil. | +3,1 % |
| tento rok | 620,2 mil. | 642,8 mil. | −3,5 % |
| budúci rok | 680,9 mil. | 620,2 mil. | +9,8 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| Saxonov Serge WilsonChief Executive Officer | predaj | 2,0 mil. | 22.09. |
| Suliman ShehnaazDirector | predaj | 464 668 | 22.09. |
| Taich AdamChief Financial Officer | predaj | 3,0 mil. | 09.09. |
| Stuelpnagel John RDirector | predaj | 1,2 mil. | 03.09. |
| Saxonov Serge WilsonChief Executive Officer | dar akcií | – | 01.09. |
| Saxonov Serge WilsonChief Executive Officer | predaj | 667 901 | 26.08. |
| Saxonov Serge WilsonChief Executive Officer | predaj | 1,2 mil. | 24.08. |
| Hindson Benjamin JPresident | predaj | 870 860 | 24.08. |
| Taich AdamChief Financial Officer | predaj | 1,1 mil. | 24.08. |
| Suliman ShehnaazDirector | predaj | 140 478 | 24.08. |
| Saxonov Serge WilsonChief Executive Officer | dar akcií | – | 20.08. |
| Teichmann Sarah A.Director | predaj | 432 279 | 14.08. |
Kto vlastní akcie
Slávni investori: Cathie Wood · 2.5 % Stanley Druckenmiller · 0.4 % · nový Ray Dalio · 0.0 %
FMR, LLC14,67 %
Blackrock Inc.8,99 %
ARK Investment Management, LLC8,32 %
Vanguard Portfolio Management LLC5,81 %
Quantinno Capital Management, LP4,55 %
Vanguard Capital Management LLC4,23 %
Price (T.Rowe) Associates Inc3,78 %
Sumitomo Mitsui Trust Group, Inc.3,49 %
O firme (popis z Yahoo Finance, anglicky)
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
Technické signály
- Prekúpené – RSI 78 – rast je natiahnutý, hrozí korekcia
- Rastový trend – Kurz nad SMA50 aj SMA200, SMA50 nad SMA200
- Pri 52t maxime – Obchoduje sa pri ročnom maxime – silné momentum
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou TXG.